Your browser doesn't support javascript.
loading
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.
Chen, Shanshan; Han, Yiqun; Ouyang, Quchang; Lu, Jianguo; Zhang, Qingyuan; Yang, Shun'e; Wang, Jingfen; Huang, Haixin; Liu, Hong; Shao, Zhimin; Li, Hui; Chen, Zhendong; Sun, Sanyuan; Geng, Cuizhi; Lu, Junguo; Sun, Jianwei; Wang, Jiayu; Xu, Binghe.
Afiliación
  • Chen S; Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
  • Han Y; Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
  • Ouyang Q; Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital, Changsha, Hunan, China.
  • Lu J; Department of General Surgery, Xi'an Tangdu Hospital, Xi'an, Shanxi, China.
  • Zhang Q; Department of Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
  • Yang S; Department of Breast Cancer and Lymphoma, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
  • Wang J; Department of Internal Medicine, Linyi Tumor Hospital, Linyi, Shandong, China.
  • Huang H; Department of Oncology, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China.
  • Liu H; Department of Breast Surgery, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Shao Z; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Li H; Department of Breast Surgery, Sichuan Province Tumor Hospital, Chengdu, Sichuan, China.
  • Chen Z; Department of Medical Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Sun S; Department of Medical Oncology, Central Hospital of Xuzhou, the Cancer Institute of Southeast University, Xuzhou, Jiangsu, China.
  • Geng C; First Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Lu J; Department of Medical Oncology, Nantong Tumor Hospital, Nantong, Jiangsu, China.
  • Sun J; Department of Tumor, Yunnan First People's Hospital, Kunming, Yunnan, China.
  • Wang J; Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. wangjiayu8778@sina.com.
  • Xu B; Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. xubingheBM@163.com.
BMC Cancer ; 21(1): 341, 2021 Mar 31.
Article en En | MEDLINE | ID: mdl-33789616
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Albúmina Sérica / Factor Estimulante de Colonias de Granulocitos / Antraciclinas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Albúmina Sérica / Factor Estimulante de Colonias de Granulocitos / Antraciclinas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido